0.2876
price up icon13.14%   0.035
after-market After Hours: .29 0.0024 +0.83%
loading

Glycomimetics Inc Stock (GLYC) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
100.00%
-
0.01 - - -
Operating Expenses
15.77%
11.12
9.6008 9.8135 8.9299 10.94
Operating Income/Loss
15.89%
-11.12
-9.5908 -9.8135 -8.9299 -10.94
Income/Loss From Continuing Operations Before Tax
18.26%
-10.74
-9.0786 -9.2025 -8.2589 -10.36
Income Tax Expense/Benefit, Current
-
- - - -
Income/Loss From Continuing Operations After Tax
18.26%
-10.74
-9.0786 -9.2025 -8.2589 -10.36
Net Income/Loss
18.26%
-10.74
-9.0786 -9.2025 -8.2589 -10.36
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
18,292%
64.46
0.3505 64.35 64.28 60.35
Diluted Average Shares
18,292%
64.46
0.3505 64.35 64.28 60.35
Basic Earnings Per Share
21.43%
-0.17
-0.14 -0.14 -0.13 -0.17
Diluted Earnings Per Share
21.43%
-0.17
-0.14 -0.14 -0.13 -0.17
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.46%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 2.77%
biotechnology ONC
$226.89
price up icon 0.17%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):